CN116898098A - Boletus peptide anti-alcoholic formula and raw material preparation method - Google Patents
Boletus peptide anti-alcoholic formula and raw material preparation method Download PDFInfo
- Publication number
- CN116898098A CN116898098A CN202310897236.9A CN202310897236A CN116898098A CN 116898098 A CN116898098 A CN 116898098A CN 202310897236 A CN202310897236 A CN 202310897236A CN 116898098 A CN116898098 A CN 116898098A
- Authority
- CN
- China
- Prior art keywords
- parts
- liver
- lemon
- powder
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002994 raw material Substances 0.000 title claims abstract description 29
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 25
- 230000002075 anti-alcohol Effects 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 241000222455 Boletus Species 0.000 title description 3
- 210000004185 liver Anatomy 0.000 claims abstract description 48
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 35
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 35
- 230000000694 effects Effects 0.000 claims abstract description 32
- 240000008042 Zea mays Species 0.000 claims abstract description 30
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 30
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 30
- 235000005822 corn Nutrition 0.000 claims abstract description 30
- 241000283690 Bos taurus Species 0.000 claims abstract description 22
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 22
- 244000010000 Hovenia dulcis Species 0.000 claims abstract description 19
- 235000008584 Hovenia dulcis Nutrition 0.000 claims abstract description 19
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 19
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 19
- 235000021336 beef liver Nutrition 0.000 claims abstract description 17
- 108010068370 Glutens Proteins 0.000 claims abstract description 14
- 235000021312 gluten Nutrition 0.000 claims abstract description 14
- 235000012054 meals Nutrition 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims description 38
- 239000000284 extract Substances 0.000 claims description 36
- 239000007788 liquid Substances 0.000 claims description 24
- 241000723353 Chrysanthemum Species 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000001694 spray drying Methods 0.000 claims description 18
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 230000009849 deactivation Effects 0.000 claims description 15
- 229940088598 enzyme Drugs 0.000 claims description 15
- 239000006228 supernatant Substances 0.000 claims description 15
- 108010038807 Oligopeptides Proteins 0.000 claims description 12
- 102000015636 Oligopeptides Human genes 0.000 claims description 12
- 238000002386 leaching Methods 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 10
- 238000001179 sorption measurement Methods 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 7
- 239000004365 Protease Substances 0.000 claims description 6
- 239000004927 clay Substances 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 235000018102 proteins Nutrition 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 108091005658 Basic proteases Proteins 0.000 claims description 3
- 108090000526 Papain Proteins 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 210000003195 fascia Anatomy 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 229940055729 papain Drugs 0.000 claims description 3
- 235000019834 papain Nutrition 0.000 claims description 3
- 235000019419 proteases Nutrition 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 239000002893 slag Substances 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 2
- 235000013334 alcoholic beverage Nutrition 0.000 claims 1
- 229940040511 liver extract Drugs 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 20
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 9
- 108010024636 Glutathione Proteins 0.000 abstract description 7
- 229960003180 glutathione Drugs 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000004438 eyesight Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 210000005036 nerve Anatomy 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 208000004880 Polyuria Diseases 0.000 abstract 1
- 230000035619 diuresis Effects 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 abstract 1
- 206010067125 Liver injury Diseases 0.000 description 12
- 231100000753 hepatic injury Toxicity 0.000 description 12
- 230000035622 drinking Effects 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000000126 substance Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000304 hepatotoxicity Toxicity 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000007056 liver toxicity Effects 0.000 description 2
- OPMNROCQHKJDAQ-FKSUSPILSA-N loline Chemical compound C1C[C@@H]2O[C@H]3[C@H](NC)[C@@H]2N1C3 OPMNROCQHKJDAQ-FKSUSPILSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- -1 superoxide anion free radical Chemical class 0.000 description 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1
- 206010008428 Chemical poisoning Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 206010072268 Drug-induced liver injury Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- OPMNROCQHKJDAQ-UHFFFAOYSA-N festucine Natural products C1CC2OC3C(NC)C2N1C3 OPMNROCQHKJDAQ-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000000514 hepatopancreas Anatomy 0.000 description 1
- 229930183392 hovenin Natural products 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a bovine liver peptide anti-alcohol formula and a raw material preparation method, wherein the formula comprises the following raw materials: beef liver, corn gluten meal, kudzuvine root, hovenia dulcis thunb, chrysanthemum and lemon. The beneficial effects are that: the invention not only can achieve the effect of protecting the liver through the active bovine liver peptide (namely glutathione) extracted from the bovine liver, but also can add the medicinal and edible Chinese herbal medicines with the same source of medicine and food for dispelling the effects of alcohol and protecting the liver through the monarch, minister, assistant and guide compatibility principle, and the formula has the effects of sobering up and protecting the liver, soothing the nerves and improving eyesight, clearing heat and detoxicating, and promoting diuresis and treating stranguria.
Description
Technical Field
The invention belongs to the field of nutritional foods, and particularly relates to a beef liver peptide anti-alcohol formula and a raw material preparation method.
Background
The liver is an organ in the body that is mainly metabolic functions and plays a role in deoxidation, storage of hepatic glucose, synthesis of secreted proteins, and the like in the body. The liver also produces bile in the digestive system. The liver is the largest organ in the viscera of the human body, located in the abdominal position in the human body, under the right diaphragm, at the front end of the gallbladder and in front of the right kidney, above the stomach. The liver is the largest digestive gland in the digestive system of human body and is a reddish brown V-shaped organ. The liver is also an important organ of metabolism. Liver is a fragile organ, and after invasion of pathogenic factors such as viruses and the like into the liver, the liver can be caused to have normal function decline, most liver diseases can be cured, but a small number of liver diseases are converted into chronic hepatitis.
Liver injury can be classified into chemical liver injury, pathological liver injury and violent liver injury according to etiology. Wherein, the violent liver injury is obviously rapid and serious; pathological liver injury and chemical liver injury are the most common.
Chemical liver injury is mainly caused by chemical drug poisoning, allergy and the like, and can cause liver injury or liver function abnormality such as drug hepatitis, alcoholic liver, organic pesticide poisoning and the like. However, the most common and rising drug-induced liver injury is caused, and with the continuous development of new drugs, the liver toxicity of drugs is a difficult problem, and it is reported that recent thousands of drugs can cause liver injury, the development of biological technology will reduce the risk of certain liver toxicity of drugs, the key factor of alcoholic liver disease is alcohol, the alcohol oxidation causes liver and other organ injury, and the reduction of drinking volume and even abstinence from alcohol are the basis of treatment.
Glutathione is clinically used as an important pharmacological component for protecting liver, and currently, glutathione tablets or additives of medicines are clinically used for protecting liver, so that the glutathione is widely used for treating alcoholic liver injury, primary liver cancer, viral hepatitis and the like, has good curative effects, can improve liver microcirculation by increasing the content of nitric oxide in liver tissues, has important roles in animals and plants, and has high content in animal livers of 100-1000 mg/100g;
however, the administration of glutathione alone is easy to cause the disadvantage of inadequacy, and the effect of glutathione alone cannot be fully stimulated, so that the effect after administration is poor.
Disclosure of Invention
The invention aims to provide a beef liver peptide anti-alcoholic formula and a raw material preparation method for solving the problem of avoiding alcoholic liver injury after drinking.
In order to achieve the technical purpose, the invention provides the following technical scheme:
the invention provides a bovine liver peptide anti-alcohol formula which is prepared from the following raw materials: beef liver, corn gluten meal, kudzuvine root, hovenia dulcis thunb, chrysanthemum and lemon.
Preferably, the material comprises the following raw materials in parts by weight: 30-35 parts of beef liver, 20-25 parts of corn gluten meal, 15-20 parts of kudzuvine root, 10-15 parts of hovenia dulcis thunb, 5-10 parts of chrysanthemum and 1-5 parts of lemon.
Preferably, the material comprises the following raw materials in parts by weight: 35 parts of beef liver, 25 parts of corn gluten meal, 15 parts of kudzuvine root, 10 parts of hovenia dulcis thunb, 5 parts of chrysanthemum and 5 parts of lemon.
The invention also provides a formula for preparing the bovine liver peptide for dispelling the effects of alcohol and a preparation method of raw materials, which are characterized in that 35 parts of bovine liver, 25 parts of corn gluten meal, 15 parts of kudzuvine root, 10 parts of hovenia dulcis thunb, 5 parts of chrysanthemum and 5 parts of lemon are respectively weighed according to the weight parts of the bovine liver, the corn gluten meal, the kudzuvine root, the hovenia dulcis thunb, the chrysanthemum and the lemon, and the bovine liver peptide, the corn oligopeptide powder, the kudzuvine root extract, the hovenia dulcis thunb extract, the chrysanthemum extract and the lemon powder are respectively prepared by the following extraction methods of the 6 extracts:
bovine liver peptide powder: mechanically removing the outer fascia of the beef liver, cutting into 5 x 5cm blocks, soaking and cleaning, homogenizing by a colloid mill, and extracting the homogenized feed liquid by enzymolysis: adding 2 times of water, heating the raw material liquid to 55 ℃, adding animal protease (2 ten thousand U/g) with the concentration of 1% relative to the substrate, and carrying out enzymolysis for 4 hours; after enzymolysis, carrying out enzyme deactivation treatment on the raw material liquid at 90 ℃ for 30min, adding activated clay for adsorption at the same time of enzyme deactivation, wherein the adsorption time is 30min, and the adding amount is 2% of the volume of the feed liquid; the enzyme deactivation adsorption adopts a horizontal centrifuge for centrifugation, the discharge slag and the activated clay are separated, and the supernatant fluid is taken; purifying with 10kDa ultrafilter membrane; concentrating the purified feed liquid to 40% by double effect, and spray drying to obtain liver peptide powder;
corn oligopeptide powder: after the corn protein powder is dissolved by adding water, the feed liquid ratio is 1:3, heating to 45 ℃, adding alkaline protease (1 kiloU/g) and papain (2 kiloU/g) with the concentration of 0.5% relative to the substrate, carrying out enzymolysis for 3 hours, carrying out enzyme deactivation treatment on raw material liquid at 90 ℃ for 30 minutes after enzymolysis, carrying out tubular separation at 14000rpm after enzyme deactivation is finished, taking supernatant, and purifying by a 1kDa ultrafiltration membrane; concentrating the purified feed liquid to 40% by double effect, and spray drying to obtain corn oligopeptide powder;
radix Puerariae extract: pulverizing radix Puerariae with 80 mesh, adding 10 times of water, leaching with 90 deg.C water for 3 hr, continuously leaching for 3 times, centrifuging, collecting supernatant, concentrating to 1/5 of the total volume with double effect concentration, and spray drying to obtain radix Puerariae extract;
semen Hoveniae extract: pulverizing semen Hoveniae into coarse powder, and leaching with 10 times of water at 70deg.C for 2-3 hr; centrifuging, collecting supernatant, concentrating with double effect concentration to 1/5 of the total volume, and spray drying to obtain semen Hoveniae extract;
flos Chrysanthemi extract: crushing chrysanthemum into coarse powder, and leaching with 10 times of water at 70 ℃ for 2-3 h; centrifuging, collecting supernatant, concentrating by double effect concentration to 1/5 of the total volume, and spray drying to obtain flos Chrysanthemi extract;
lemon powder: cleaning lemon, peeling, removing pulp and seeds, crushing, squeezing, centrifuging at 14000rpm to obtain clear lemon juice, adjusting pH to 4.5-5.5 with sodium bicarbonate, adding starch for molecular embedding, and spray drying to obtain raw lemon pulp powder.
The efficacy of the formula raw materials in the invention is as follows:
bovine liver: regulating liver function; promoting metabolism; improving the antitoxic function of liver, enhancing immunity, and regulating bile production and biliary tract tension; protecting liver and resisting toxic materials.
Corn oligopeptide powder: corn oligopeptides are an angiotensin converting enzyme inhibitor which achieves a blood pressure lowering effect by inhibiting the activity of angiotensin converting enzyme. Has antioxidant effect similar to SOD (superoxide dismutase), has strong scavenging effect on superoxide anion free radical and hydroxyl free radical, and has unique amino acid composition, which is beneficial to promoting alcohol metabolism.
Radix Puerariae extract: sobering up, reducing blood sugar, heart failure, hypertension and myocardial infarction, and is clinically used for treating cardiovascular and cerebrovascular diseases, cancers, parkinsonism, alzheimer's disease, diabetes, diabetic complications and the like.
Semen Hoveniae extract: sobering up, tranquillizing, dispelling wind and dampness, is rich in loline and hovenin, and has the pharmacological effects of protecting liver, dispelling alcohol, resisting tumor, preventing and treating cancer, etc.
Flos Chrysanthemi extract: dispelling pathogenic wind, clearing heat, suppressing hyperactive liver, improving eyesight, lowering blood pressure, and is rich in chlorogenic acid, reducing body fat, resisting oxidation and aging, regulating blood sugar, resisting bacteria, relieving inflammation, resisting virus, etc.
Lemon powder: the lemon can remove fishy smell, is rich in organic acid, and can interact with ethanol to form esters, thereby achieving the purpose of dispelling effects of alcohol.
The beneficial effects are that: the invention takes bovine liver peptide (glutathione) as a monarch, corn oligopeptide powder as a minister, kudzuvine root extract, hovenia dulcis thunb extract and chrysanthemum extract as an assistant, and lemon powder as a guide. So as to achieve the effects of dispelling the effects of alcohol, protecting liver, soothing the nerves, improving eyesight and the like, ensure the edible safety and effectiveness by reasonable collocation of homology of medicine and food, avoid the effect of singly supplementing a certain kind of medicine, and avoid the phenomenon of hesitation.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the technical solutions of the present invention will be described in detail below. It will be apparent that the described embodiments are only some, but not all, embodiments of the invention. All other embodiments, based on the examples herein, which are within the scope of the invention as defined by the claims, will be within the scope of the invention as defined by the claims.
Embodiment one:
the bovine liver peptide anti-alcoholic formula consists of the following raw materials in parts by weight: 30 parts of beef liver, 20 parts of corn gluten meal, 15 parts of kudzuvine root, 10 parts of hovenia dulcis thunb, 5 parts of chrysanthemum and 1 part of lemon.
Embodiment two:
the bovine liver peptide anti-alcoholic formula consists of the following raw materials in parts by weight: 35 parts of beef liver, 25 parts of corn gluten meal, 15 parts of kudzuvine root, 10 parts of hovenia dulcis thunb, 5 parts of chrysanthemum and 5 parts of lemon.
Embodiment III:
the anti-alcoholic formula of the boletus peptide and the raw material preparation method thereof comprise the following raw materials in parts by weight: 35 parts of beef liver, 25 parts of corn gluten meal, 20 parts of kudzuvine root, 15 parts of hovenia dulcis thunb, 10 parts of chrysanthemum and 5 parts of lemon.
The raw material preparation method of the bovine liver peptide anti-alcoholic formula comprises the steps of weighing the bovine liver, the corn gluten meal, the kudzuvine root, the hovenia dulcis thunb, the chrysanthemum and the lemon according to the weight parts of the bovine liver, the corn gluten meal, the kudzuvine root, the hovenia dulcis thunb, the chrysanthemum and the lemon in the third embodiment, and respectively preparing the bovine liver peptide, the corn oligopeptide powder, the kudzuvine root extract, the hovenia dulcis thunb extract, the chrysanthemum extract and the lemon powder into the 6 extract extraction methods as follows:
bovine liver peptide powder: mechanically removing the outer fascia of the beef liver, cutting into 5 x 5cm blocks, soaking and cleaning, homogenizing by a colloid mill, and extracting the homogenized feed liquid by enzymolysis: adding 2 times of water, heating the raw material liquid to 55 ℃, adding animal protease (2 ten thousand U/g) with the concentration of 1% relative to the substrate, and carrying out enzymolysis for 4 hours; after enzymolysis, carrying out enzyme deactivation treatment on the raw material liquid at 90 ℃ for 30min, adding activated clay for adsorption at the same time of enzyme deactivation, wherein the adsorption time is 30min, and the adding amount is 2% of the volume of the feed liquid; the enzyme deactivation adsorption adopts a horizontal centrifuge for centrifugation, the discharge slag and the activated clay are separated, and the supernatant fluid is taken; purifying with 10kDa ultrafilter membrane; concentrating the purified feed liquid to 40% by double effect, and spray drying to obtain liver peptide powder;
corn oligopeptide powder: after the corn protein powder is dissolved by adding water, the feed liquid ratio is 1:3, heating to 45 ℃, adding alkaline protease (1 kiloU/g) and papain (2 kiloU/g) with the concentration of 0.5 percent relative to the substrate, carrying out enzymolysis for 3 hours, carrying out enzyme deactivation treatment on the raw material liquid at 90 ℃ for 30 minutes after enzymolysis, carrying out tubular separation at 14000rpm after enzyme deactivation is finished, taking supernatant, and purifying by a 1kDa ultrafiltration membrane; concentrating the purified feed liquid to 40% by double effect, and spray drying to obtain corn oligopeptide powder;
radix Puerariae extract: pulverizing radix Puerariae with 80 mesh, adding 10 times of water, leaching with 90 deg.C water for 3 hr, continuously leaching for 3 times, centrifuging, collecting supernatant, concentrating to 1/5 of the total volume with double effect concentration, and spray drying to obtain radix Puerariae extract;
semen Hoveniae extract: pulverizing semen Hoveniae into coarse powder, and leaching with 10 times of water at 70deg.C for 2-3 hr; centrifuging, collecting supernatant, concentrating by double effect concentration to 1/5 of the total volume, and spray drying to obtain semen Hoveniae extract;
flos Chrysanthemi extract: crushing chrysanthemum into coarse powder, and leaching with 10 times of water at 70 ℃ for 2-3 h; centrifuging, collecting supernatant, concentrating by double effect concentration to 1/5 of the total volume, and spray drying to obtain flos Chrysanthemi extract;
lemon powder: cleaning lemon, peeling, removing pulp and seeds, crushing, squeezing, centrifuging at 14000rpm to obtain clear lemon juice, adjusting pH to 4.5-5.5 with sodium bicarbonate, adding starch for molecular embedding, and spray drying to obtain raw lemon pulp powder.
And (3) manufacturing a finished product: the ingredients of the formula are all extracts, the ingredients are uniformly mixed by a V-shaped mixer, then the mixture is conveyed to a boiling granulator for mixing, granulating (the binder is purified water), and drying (the temperature is 135 ℃) to obtain brown small granular solid matters, and the brown small granular solid matters are filled and packaged to obtain the final product.
The specification of bagged finished products: 5 g/pack;
traits: brown granules; smell lemon flavor; lemon fruit taste with sweet taste;
preservation conditions: room temperature, sealing and light shielding;
physicochemical properties and biological characteristics: physicochemical properties and microbiological characteristics meet standard requirements;
the eating method comprises the following steps: the daily intake is less than or equal to 15g (namely 3 bags), and 600ml of warm water is used for brewing and drinking;
eating taboos: pregnant women and children under 14 years old are not suitable for taking; the patients with protein allergy cannot take the medicine.
Effect analysis
The above examples were given to 60 subjects who were drinking, aged 30-60 years, and equally divided into 2 experimental groups (formulas) and control groups (placebo), each group of 30 persons was blind, the subjects were not drinking for nearly 7 days, and the subjects were empty stomach in the test, and the same alcohol was used and the volume of alcohol was consistent (100 ml, 43 °). Blood alcohol concentration was measured 1 hour after drinking, data were recorded, and then subjects took 3 bags of product continuously, and after 1 hour, the measurement was performed again, and the change in alcohol content was analyzed in a lump. The evaluation summary results are as follows:
note that: the effect is obvious: the alcohol degree of alcohol meter test decreases by 30% -50% in unit time; the effect is effective: the alcohol degree of alcohol meter test decreases by 10% -30% in unit time; the effect is invalid: the alcohol degree of alcohol tester is reduced by less than 10% in unit time; the effective rate is as follows: effective rate (%) = (effective+significant)/group population.
From a summary table, the formula is effective in alleviating hangover, and the effective rate is 96.7%.
The present invention is not limited to the above-mentioned embodiments, and any person skilled in the art, based on the technical solution of the present invention and the inventive concept thereof, can be replaced or changed equally within the scope of the present invention.
Claims (4)
1. The bovine liver peptide anti-alcohol formula is characterized by comprising the following raw materials: ox liver, corn protein powder, kudzuvine root, hovenia dulcis thunb, chrysanthemum and lemon.
2. The bovine liver peptide anti-alcohol formula according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 30-35 parts of beef liver, 20-25 parts of corn gluten meal, 15-20 parts of kudzuvine root, 10-15 parts of hovenia dulcis thunb, 5-10 parts of chrysanthemum and 1-5 parts of lemon.
3. A formulation for neutralizing the effect of alcoholic drinks of bovine liver peptide according to claim 2, wherein: the optimal proportion is composed of the following raw materials in parts by weight: 35 parts of beef liver, 25 parts of corn gluten meal, 15 parts of kudzuvine root, 10 parts of hovenia dulcis thunb, 5 parts of chrysanthemum and 5 parts of lemon.
4. A method for preparing raw materials for preparing the anti-alcoholic formulation of the boletpeptide of claim 3, which is characterized in that: the method for preparing the beef liver extract comprises the following steps of respectively weighing beef liver, corn gluten meal, kudzuvine root, hovenia dulcis thunb, chrysanthemum and lemon according to the parts by weight, and respectively preparing the beef liver peptide, corn oligopeptide powder, kudzuvine root extract, hovenia dulcis thunb extract, chrysanthemum extract and lemon powder according to the parts by weight:
bovine liver peptide powder: mechanically removing the outer fascia of the beef liver, cutting into 5 x 5cm blocks, soaking and cleaning, homogenizing by a colloid mill, and extracting the homogenized feed liquid by enzymolysis: adding 2 times of water, heating the raw material liquid to 55 ℃, adding animal protease (2 ten thousand U/g) with the concentration of 1% relative to the substrate, and carrying out enzymolysis for 4 hours; after enzymolysis, carrying out enzyme deactivation treatment on the raw material liquid at 90 ℃ for 30min, adding activated clay for adsorption at the same time of enzyme deactivation, wherein the adsorption time is 30min, and the adding amount is 2% of the volume of the feed liquid; the enzyme deactivation adsorption adopts a horizontal centrifuge for centrifugation, the discharge slag and the activated clay are separated, and the supernatant fluid is taken; purifying with 10kDa ultrafilter membrane; concentrating the purified feed liquid to 40% by double effect, and spray drying to obtain liver peptide powder;
corn oligopeptide powder: after the corn protein powder is dissolved by adding water, the feed liquid ratio is 1:3, heating to 45 ℃, adding alkaline protease (1 kiloU/g) and papain (2 kiloU/g) with the concentration of 0.5 percent relative to the substrate, carrying out enzymolysis for 3 hours, carrying out enzyme deactivation treatment on the raw material liquid at 90 ℃ for 30 minutes after enzymolysis, carrying out tubular separation at 14000rpm after enzyme deactivation is finished, taking supernatant, and purifying by a 1kDa ultrafiltration membrane; concentrating the purified feed liquid to 40% by double effect, and spray drying to obtain corn oligopeptide powder;
radix Puerariae extract: pulverizing radix Puerariae with 80 mesh, adding 10 times of water, leaching with 90 deg.C water for 3 hr, continuously leaching for 3 times, centrifuging, collecting supernatant, concentrating to 1/5 of the total volume with double effect concentration, and spray drying to obtain radix Puerariae extract;
semen Hoveniae extract: pulverizing semen Hoveniae into coarse powder, and leaching with 10 times of water at 70deg.C for 2-3 hr; centrifuging, collecting supernatant, concentrating by double effect concentration to 1/5 of the total volume, and spray drying to obtain semen Hoveniae extract;
flos Chrysanthemi extract: crushing chrysanthemum into coarse powder, and leaching with 10 times of water at 70 ℃ for 2-3 h; centrifuging, collecting supernatant, concentrating by double effect concentration to 1/5 of the total volume, and spray drying to obtain flos Chrysanthemi extract;
lemon powder: cleaning lemon, peeling, removing pulp and seeds, crushing, squeezing, centrifuging at 14000rpm to obtain clear lemon juice, adjusting pH to 4.5-5.5 with sodium bicarbonate, adding starch for molecular embedding, and spray drying to obtain raw lemon pulp powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310897236.9A CN116898098A (en) | 2023-07-20 | 2023-07-20 | Boletus peptide anti-alcoholic formula and raw material preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310897236.9A CN116898098A (en) | 2023-07-20 | 2023-07-20 | Boletus peptide anti-alcoholic formula and raw material preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116898098A true CN116898098A (en) | 2023-10-20 |
Family
ID=88352665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310897236.9A Pending CN116898098A (en) | 2023-07-20 | 2023-07-20 | Boletus peptide anti-alcoholic formula and raw material preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116898098A (en) |
-
2023
- 2023-07-20 CN CN202310897236.9A patent/CN116898098A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI516280B (en) | Use of chenopodium formosanum extract for manufacture of composition for enhancing secretion of collagen and preventing cutaneous aging | |
CN112273649B (en) | Antioxidant and anti-aging composition, preparation method and application | |
CN110269224A (en) | A kind of elder jelly and preparation method thereof | |
US7846484B2 (en) | Composition comprising Hovenia dulcis thunb. extract, Lindera obtusiloba blume extract, or herbal mixture extract thereof | |
CN112690450A (en) | Composition for relieving alcoholism and protecting liver, preparation method thereof and product containing composition | |
CN112618608A (en) | Composition with function of dispelling effects of alcohol and preparation method and application thereof | |
CN104739964B (en) | A kind of snail sobering preparation and preparation method thereof | |
CN109589400B (en) | Composition with neuroprotective effect | |
US9737583B2 (en) | Composition for prevention or treatment of acute renal failure including herbal extract or fraction thereof as active ingredient | |
KR20210063657A (en) | A natural tea removing the effect of hangover contained the extract material in Hovenia dulcis and a cactus | |
CN116898098A (en) | Boletus peptide anti-alcoholic formula and raw material preparation method | |
JP2003063981A (en) | Nourishing tonic | |
CN108619484B (en) | Biological protein extracted from liver-protecting and alcoholism-relieving silkworm chrysalis | |
CN106928376A (en) | The separation method of skunk bush polysaccharide and its application | |
CN109805235B (en) | Wheat-flavor composite polypeptide solid beverage for assisting in reducing hypertension, hyperglycemia and hyperlipidemia, and preparation method and application thereof | |
CN107467654B (en) | Kelp and sea cucumber compound extract and preparation method and application thereof | |
CN101596268B (en) | Application of garlic total saponin in preparing medicaments and foods for resisting oxidative stress damage | |
CN105597083B (en) | A kind of pair of liver kidney has health food of auxiliary protection function and preparation method thereof | |
CN109275914A (en) | Black fungus polypeptide function edible composition and its preparation method and application | |
JP2006193501A (en) | Adiponectin regulating agent and food, drink, food additive and medicine containing the same | |
CN104783156B (en) | A kind of preparation method of the black vinegar ferment with cosmetology function | |
CN111528386B (en) | Hawthorn and natto solid beverage and preparation method thereof | |
US20240123019A1 (en) | Composition for treating or ameliorating liver disease and liver dysfunction comprising zizania latifolia extract | |
KR101229092B1 (en) | Manufacturing method of cellulose derived from microbe using halloysitum rubrum and health-supporting food composition for diet | |
KR20090021799A (en) | Sweet flavorous the collagen ganoderma lucidum tea and water |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |